Editor's Note
The Food and Drug Administration (FDA) on February 28 issued a Safety Communication on the safety and effectiveness of using robotically-assisted surgical devices in mastectomy procedures or in the prevention or treatment of cancer in women.
The FDA cited limited, preliminary evidence that the use of robotically-assisted surgical devices for treatment or prevention of cancers that primarily (breast) or exclusively (cervical) affect women may be linked to diminished long-term survival.
The promise of quicker recovery and fewer complications from sedation,…
This past February, the OR Business Management Conference, held in…
New York, New York (January 31, 2024)–Sonio today announced that…